Parkinson's Disease

Parkinson's Disease is a progressive neurodegenerative disorder characterized by loss of muscle control, including trembling of the limbs and impaired balance. Here is the latest research on this disease.

April 18, 2021

NF‑κB is negatively associated with Nurr1 to reduce the inflammatory response in Parkinson's disease.

Molecular Medicine Reports
Hua GaoXinling Yang
April 18, 2021

Potential medicinal value of celastrol and its synthesized analogues for central nervous system diseases.

Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie
Xue BaiYu-Ping Tang
April 18, 2021

Electrogastrography for diagnosis of early-stage Parkinson's disease.

Parkinsonism & Related Disorders
Nobuyuki ArakiMasato Asahina
April 18, 2021

Pharmacokinetics of Opicapone and Its Metabolites in Healthy White and Chinese Subjects.

Clinical Pharmacology in Drug Development
Wei XueKexin Li
April 18, 2021

Nitric oxide and dopamine metabolism converge via mitochondrial dysfunction in the mechanisms of neurodegeneration in Parkinson's disease.

Archives of Biochemistry and Biophysics
Carla Nunes, João Laranjinha
April 18, 2021

Early suspicion of progressive supranuclear palsy using dopamine transporter imaging: an illustrative case presenting with levodopa-responsive parkinsonism.

Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Hyunjin JuKyum-Yil Kwon
April 18, 2021

Natural antioxidants in the management of Parkinson's disease: Review of evidence from cell line and animal models.

Journal of Integrative Medicine
Reem Abdul-LatifThilini Thrimawithana
April 18, 2021

Neuropsychological correlates of prospective memory: A comparison between tremor-dominant Parkinson's disease and cervical dystonia.

Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
Alfonsina D'IorioGabriella Santangelo
April 17, 2021

Bifurcation analyses and potential landscapes of a cortex-basal ganglia-thalamus model.

IET Systems Biology
Chenri YanYuanhong Bi
April 17, 2021

Targeting Adenosine Receptors in Neurological Diseases.

Cellular Reprogramming
Muhmmad AtifQaisar Raza
April 17, 2021

An α-synuclein decoy peptide prevents cytotoxic α-synuclein aggregation caused by fatty acid binding protein 3.

The Journal of Biological Chemistry
Naoya FukuiYasushi Kawata
April 17, 2021

Hypoxia and Brain Aging: Neurodegeneration or Neuroprotection?

Ageing Research Reviews
Johannes BurtscherGrégoire P Millet
April 16, 2021
Open Access

The Density of Calretinin Striatal Interneurons Is Decreased in 6-OHDA-Lesioned Mice

Sarah PetryszynMartin Parent
April 16, 2021
Open Access

Dopaminergic but not Cholinergic Neurodegeneration is Correlated with Gait Disturbances in PINK1 Knockout Rats

BioRxiv : the Preprint Server for Biology
V. M. DeAngeloGeorge C McConnell
April 16, 2021

Fucoidan: a promising agent for brain injury and neurodegenerative disease intervention.

Food & Function
Yingying WangShanshan Ma
April 16, 2021

Meta-Analysis of Cognition in Parkinson's Disease Mild Cognitive Impairment and Dementia Progression.

Neuropsychology Review
Elizabeth R WallaceLisa M Koehl
April 16, 2021

Nanoemulsion Improves the Neuroprotective Effects of Curcumin in an Experimental Model of Parkinson's Disease.

Neurotoxicity Research
Osmar Vieira Ramires JúniorMariana Appel Hort

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.


TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2021 Meta ULC. All rights reserved